Cabaron, Jayvee .
HRN: 22-05-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 1.5GM (VIAL)
10/02/2022
10/09/2022
IVT
1.5grams
Q8h
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes